Overview

Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether topiramate effective in treating dizziness symptoms that are associated with migraine headaches.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of California, San Francisco
Collaborator:
American Academy of Otolaryngology-Head and Neck Surgery Foundation
Treatments:
Lactulose
Topiramate
Criteria
Inclusion Criteria:

- Clinical diagnosis of migraine-associated dizziness.

Exclusion Criteria:

- Previous or current use of topiramate prior to study enrollment.

- Need for continued use of the following medications for any medical reason during the
study: ergots, anti-epileptics, beta-blockers, calcium channel blockers, monoamine
oxidase inhibitors, high-dose magnesium, high-dose riboflavin, corticosteroids, local
anesthetics, botulinum toxin, or herbal preparations.

- History of nephrolithiasis.

- Women whom are pregnant or breastfeeding.

- Patients with known sensitivity to topiramate.

- Patients with a history of glaucoma.

- Patients with severe medical condition(s) that in the view of the investigator
prohibits participation in the study.